Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Celltrion’s Vegzelma Becomes Fourth US-Approved Bevacizumab
Estimated US Market Launch Date Is H1 2023
Oct 11 2022
•
By
Rosalind Rei
• Source: Shutterstock
More from Biosimilars
More from Products